The role of the TP53 gene during rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide

Experimental and Toxicologic Pathology

Volumn 63, Issue 5, 2011, Pages 483-489

  Minicucci, E M ^a   Ribeiro, D A ^b   da Silva, G N ^a   Pardini, M I M C ^a   Montovani, J C ^a   Salvadori, D M F ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

4 Nitroquinoline 1 oxide; Direct DNA sequencing; Oral squamous cell carcinoma; Rat tongue mucosa; Tp53

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; DRINKING WATER; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; DNA SEQUENCE; EPITHELIAL DYSPLASIA; EPITHELIUM; EXON; GENE; GENE FUNCTION; GENE MUTATION; HISTOPATHOLOGY; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MALE; MOUTH DISEASE; MOUTH DYSPLASIA; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SQUAMOUS CELL CARCINOMA; TONGUE; TONGUE CANCER; TONGUE SQUAMOUS CELL CARCINOMA; TP53 GENE;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; CARCINOGENICITY TESTS; GENES, P53; IMMUNOHISTOCHEMISTRY; MALE; MUTAGENS; MUTATION; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; TONGUE NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 79954614614     PISSN: 09402993     EISSN: 16181433     Source Type: Journal    
DOI: 10.1016/j.etp.2010.03.009     Document Type: Article

References (52)

1. Abbas NF, Labib El-Sharkawy S, Abbas EA, Abdel Monem El-Shaer M Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007, 103:385-390.
2. Bjelogrlic NM, Mäkinen M, Stenbäck F, Vähäkangas K. Benzo(a)pyrene-7,8-diol-9,10-epoxide-DNA adducts and increased p53 protein in mouse skin. Carcinogenesis 1994, 15:771-774.
3. Bullock AN, Fersht AR. Rescuing the function of mutant p53. Nat Rev Cancer 2001, 1:68-76.
4. Califano J, van der Riet P, Westra W, Nawroz H, Clayman Gand Piantadosi S Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996, 56:2488-2492.
5. Canzian F, Ushijima T, Toyota M, Sugimiura T, Nagao M. Linkage mapping of the rat T p53 gene on Chromosome 10. Mamm. Genome 1996, 7:630-636.
6. Cavalcante Junior GB, Klumb GE, Maia RC p53 e as hematopatias malignas. Rev Bras Cancerol 2002, 48:419-427. (in Portuguese).
7. Chaves AC, Cherubini K, Herter N, Furian R, Santos DS, Squier C, et al. Characterization of p53 gene mutations in a Brazilian population with oral squamous cell carcinomas. Int J Oncol 2004, 24:295-303.
8. de Oliveira LR, Ribeiro-Silva A, Zucoloto S. Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma. J Oral Pathol Med 2007, 36:191-197.
9. El-Naggar AK, Lasi S, Luna MA, Zhou XD, Weber RS, Goepfert H. Sequential p53 mutations análisis of pre-invasive and invasive head and neck squamous carcinoma. Int J Cancer 1995, 64:196-201.
10. Gimenez-Conti IB, LaBate M, Liu F, Osterndorff E. p53 alterations in chemically induced hamster cheek-pouch lesions. Mol Carcinog 1996, 16:197-202.
11. Hayashi S, Nonoyama T, Miyajima H. Spontaneous nonthymic cell lymphomasin young Wistar rats. Vet Pathol 1989, 26:326-332.
12. Herzig M, Christofori G. Recent advances in cancer research: mouse models of tumorigenesis. Rev Biochim Biophys Acta 2002, 1602:97-113.
13. Högmo A, Börresen-Dale AL, Blegen H, Lindholm J, Kuylenstierna R, Auer G, et al. TP53 mutations do not correlate with locoregional recurrence in stage I tongue carcinomas. Anticancer Res 1999, 19:3433-3438.
14. Hollstein M, Sidransky D, Volgestein B, Harris CC. p53 mutations in human cancers. Science 1991, 253:49-53.
15. Hulla JE, Schneider RP. Structure of the rat p53 tumor suppressor gene. Nucleic Acids Res 1993, 21:713-717.
16. Kannan K, Munirajan AK, Krishnamurthy J, Bhuvarahamurthy V, Mohanprasad BK, Panishankar KH, et al. Low incidence of p53 mutations in betel quid and tobacco chewing-associated oral squamous carcinoma from India. Int J Oncol 1999, 15:1133-1136.
17. Kashiwazaki H, Hassan NM, Hamada J, Moriuchi T, Yamazaki Y, Tei K, et al. Gene expression profile changes correlated with lymph node metastasis in oral squamous cell carcinoma. Odontology 2008, 96:38-43.
18. Kitakawa D, Cabral LAG, Marques ME, Salvadori DM, Ribeiro DA. Medium-term tongue carcinogenesis assays: a comparative study between 4-nitroquinoline 1-oxide (4NQO) induced rat and dimethylbenzanthracene (DMBA) induced hamster carcinogenesis. J Exp Animal Sci 2006, 43:219-227.
19. Kuo MY, Huang JS, Hsu HC, Chiang CP, Kok SH, Kuo YS, et al. Infrequent p53 mutations in patients with areca quid chewing-associated oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 1999, 28:221-225.
20. Levine AJ. P53, the cellular gatekeeper for growth and division. Cell 1997, 88:323-331.
21. Li YQ, Pavelic ZP, Wang LJ, McDonald JS, Gleich L, Pavelic LJ Altered. p53 in microdissected, metachronous, premalignant oral lesions from the same patients. J Clin Pathol: Mol Pathol 1995, 48:269-272.
22. Lingen MW, Chang KW, McMurray SJ, Solt DB, Kies MS, Mittal BB, et al. Overexpression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exons 5-9. Head Neck 2000, 22:328-335.
23. Loro LL, Vintermyr OK, Johannessen AC. Apoptosis in normal and diseased oral tissues. Oral Dis 2005, 11:274-287.
24. May PM, May E. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 1999, 18:7621-7636.
25. Nakahara Y, Shintani S, Mihara M, Matsumura T, Hamakawa H. High frequency methylation of p16INK4A gene during 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. Oncol Rep 2004, 12:101-106.
26. Nishimura A. Changes in Bcl-2 and Bax expression in rat tongue during 4-nitroquinoline 1-oxide-induced carcinogenesis. J Dent Res 1999, 78:1264-1269.
27. Nylander K, Dabelsteen E, Hall PA. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med 2000, 29:413-425.
28. Ogawa K, Tanuma J, Hirano M, Hirayama Y, Semba I, Shisa H, et al. Selective loss of resistant alleles at p15INK4B and p16INK4A genes in chemically-induced rat tongue cancers. Oral Oncol 2006, 42:710-717.
29. Okazaki Y, Tanaka Y, Tonogi M, Yamane G. Investigation of environmental factors for diagnosing malignant potential in oral epithelial dysplasia. Oral Oncol 2002, 38:562-573.
30. Osugi Y. p53 expression in various stages of 4-nitroquinoline 1-oxide induced carcinoma in the rat tongue. J Osaka Dent Univ 1996, 30:29-35.
31. Pereira MC, Oliveira DT, Landman G, Kowalski LP. Histologic subtypes of oral squamous cell carcinoma: prognostic relevance. J Can Dent Assoc 2007, 73:339-344.
32. Polverini PH, Nor JE. Apoptosis and predisposition to oral cancer. Crit Rev Oral Biol Med 1999, 10:139-152.
33. Qin GZ, Park JY, Chen SY, Lazarus P. A high prevalence of p53 mutations in pre-malignant oral erythroplakia. Int J Cancer 1999, 80:345-348.
34. Ribeiro DA, Grilli DG, Salvadori DM. Genomic instability in blood cells is able to predict the oral cancer risk: an experimental study in rats. J Mol Histol 2008, 39:481-486.
35. Ribeiro DA, Kitakawa D, Domingues MA, Cabral LA, Marques ME, Salvadori DM. Surviving and inducible nitric oxide synthase production during 4NQO-induced rat tongue carcinogenesis: a possible relationship. Exp Mol Pathol 2007, 83:131-137.
36. Ribeiro DA, Salvadori DM, Marques ME. Abnormal expression of bcl-2 and bax in rat tongue mucosa during the development of squamous cell carcinoma induced by 4-nitroquinoline 1-oxide. Int J Exp Pathol 2005, 86:375-381.
37. Ribeiro DA, Salvadori DMF, Silva RN, Darros BR, Marques MEA. Genomic instability in non-neoplastic oral mucosa cells can predict risk during 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. Oral Oncol 2004, 40:910-915.
38. Sanguinetti CJ, Dias Neto E, Simpson AJ. Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques 1994, 17:914-921.
39. Sarasin A. An overview of the mechanisms of mutagenesis and carcinogenesis. Mutat Res 2003, 544:99-106.
40. Schwartz JL, Gu X, Kittles RA, Baptiste A, Shklar G. Experimental oral carcinoma of the tongue and buccal mucosa: possible biologic markers linked to cancers at two anatomic sites. Oral Oncol 2000, 36:225-235.
41. Shahnavaz SA, Regezi JA, Bradley G, Dube ID, Jordan RC. p53 gene mutations in sequential oral epithelial dysplasias and squamous cell carcinomas. J Pathol 2000, 190:417-422.
42. Silva RN, Ribeiro DA, Salvadori DM, Marques ME. Placental glutathione S-transferase correlates with cellular proliferation during rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide. Exp Toxicol Pathol 2007, 59:61-68.
43. Sjodren S, Inganas M, Norbert T. The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J Nat Cancer Inst 1996, 88:173-182.
44. Sugimura T, Terada M, Yokota J, Hirohashi S, Wakabayashi K. Multiple genetic alterations in human carcinogenesis. Environ Health Perspect 1992, 98:5-12.
45. Suzui M, Yoshimi N, Tanaka T, Mori H. Infrequent. Ha-ras mutations and absence of Ki-ras, N-ras and p53 mutations in 4-nitroquinoline 1-oxide-induced rat oral lesions. Mol Carcinog 1995, 14:294-298.
46. Tanaka T, Kohno H, Sakata K, Yamada Y, Hirose Y, Sugie S, et al. Modifying effects of dietary capsaicin and rotenone on 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. Carcinogenesis 2002, 23:1361-1367.
47. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 1993, 9:138-141.
48. Whyte DA, Brton CE, Shillitoe EJ. The unexplained survival of cells in oral cancer: what is the role of p53?. J Oral Pathol Med 2002, 31:125-133.
49. Wu X, Lippman SM, Lee JJ, Zhu Y, Wei V, Thomas M. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions. Cancer Res 2002, 62:2813-2818.
50. Xi S, Grandis JR. Gene therapy for the treatment of oral squamous cell carcinoma. J Dent Res 2003, 82:11-16.
51. Yeh KT, Chang JG, Lin TH, Wang YF, Tien N, Chang JY, et al. Epigenetic changes of tumor suppressor genes, P15, P16, VHL and P53 in oral cancer. Oncol Rep 2003, 10:659-663.
52. Yoshida T. Detection of p53 gene mutations in leukoplakia and well differentiated squamous cell carcinoma by polymerase chain reaction- single strand conformation polymorphism analysis. Nihon Univ J Oral Sci 1999, 25:93-101.